date,title,source
Oct-24-18,"Market Trends Toward New Normal in UROGEN PHARMA, Cimarex Energy, Boingo Wireless, TransCanada, EXTRACTION O&G, and ACADIA Pharmaceuticals  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Oct-30-18,FDA Grants Breakthrough Therapy Designation (BTD) for UroGen Pharmas UGN-101 for the Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer (LG UTUC),Business Wire
Nov-05-18,"UroGen Pharma to Report Third Quarter 2018 Financial Results on Monday, November 12, 2018",Business Wire
Nov-06-18,UroGen Pharma to Present at November 2018 Investor Conferences,Business Wire
Nov-12-18,UroGen Pharma Reports Third Quarter 2018 Financial Results and Completed UGN-101 OLYMPUS Trial Enrollment,Business Wire
Dec-03-18,"Market Trends Toward New Normal in Zillow Group, YRC Worldwide, The Home Depot, UROGEN PHARMA, ZIOPHARM Oncology, and Cinedigm  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Dec-17-18,UroGen Pharma Initiates Rolling Submission of New Drug Application (NDA) for UGN-101 for the Treatment of Low-Grade Upper Tract Urothelial Cancer (LG UTUC),Business Wire
Dec-20-18,How Many Insiders Sold UroGen Pharma Ltd. (NASDAQ:URGN) Shares?,Simply Wall St.
Jan-03-19,UroGen Pharma Appoints Elizabeth (Liz) Barrett as President and Chief Executive Officer,Business Wire
Jan-08-19,UroGen Pharma Announces Positive Results of UGN-101 from Pivotal Phase 3 OLYMPUS Trial for the Non-Surgical Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer (LG UTUC),Business Wire
Jan-22-19,UroGen Pharma Announces Proposed Public Offering of Ordinary Shares,Business Wire
Jan-23-19,UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares,Business Wire
Jan-23-19,"The Daily Biotech Pulse: PTC Therapeutics, Select Biosciences Offering, Unity Biotech Expands Early-Stage Osteoporosis Drug Study",Benzinga
Jan-24-19,Here's Why Urogen Pharma Fell as Much as 12.4% Today,Motley Fool
Jan-24-19,"The Daily Biotech Pulse: Partial Clinical Hold On Advaxis Cervical Cancer Drug, Ohr's Reverse Split, Ironwood Starts Phase 1 Trial",Benzinga
Jan-28-19,UroGen Pharma Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares,Business Wire
Jan-29-19,Don't Waste Your Money on Penny Stocks. These 3 Stocks Are Better Buys,Motley Fool
Feb-06-19,What Investors Should Know About UroGen Pharma Ltd.s (NASDAQ:URGN) Financial Strength,Simply Wall St.
Feb-19-19,"Factors of Influence in 2019, Key Indicators and Opportunity within Toyota Motor, UROGEN PHARMA, Macerich, Cosan, Middlesex Water, and Howard Hughes  New Research Emphasizes Economic Growth",GlobeNewswire
Feb-21-19,"UroGen Pharma to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, February 28, 2019",Business Wire
